|
Title | Number of subjects | Conclusion | Wound | Reference |
|
A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients | 36 patients | Highly significant reduction in bacterial load | Chronic | Isbary et al. [53] |
Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial | 24 patients | MicroPlaSter alpha: significant reduction in bacterial load MicroPlaSter beta: highly significant reduction in bacterial load | Chronic | Isbary et al. [52] |
Cold atmospheric argon plasma treatment may accelerate wound healing in chronic wounds: results of an open retrospective randomized controlled study in vivo | 70 patients | Wound healing may be accelerated by CAP, particularly for chronic venous ulcers | Chronic | Isbary et al. [78] |
The healing effect of low-temperature atmospheric-pressure plasma in pressure ulcer: a randomized controlled trial | 50 patients | CAP-treated group had significantly better PUSH (pressure ulcer scale for healing) scores and exudate amount | Chronic | Chuangsuwanich et al. [54] |
Clinical use of cold atmospheric pressure argon plasma in chronic leg ulcers: a pilot study | 16 patients | Immediate antimicrobial effects of CAP plasma almost comparable to octenidine without signs of cytotoxicity | Chronic | Ulrich et al. [55] |
Combined antibacterial effects of tissue-tolerable plasma and a modern conventional liquid antiseptic on chronic wound treatment | 34 patients | The combined use of CAP and conventional antiseptics might represent the most efficient strategy for antiseptic treatment of chronic wounds | Chronic | Klebes et al. [56] |
Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm® VU-2010): results of a monocentric, two-armed, open, prospective, randomized and controlled trial | 14 patients | PlasmaDerm® VU-2010 device is safe and effective in patients with chronic venous leg ulcers | Chronic | Brehmer et al. [51] |
Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites | 40 patients | Donor site wound areas treated with plasma showed significantly improved healing compared with placebo-treated areas | Acute | Heinlin et al. [59] |
Experimental recovery of CO2-laser skin lesions by plasma stimulation | 5 experimental case reports | Nonthermal atmospheric pressure plasma stimulation of laser skin lesion recovery looks promising | Acute | Metelmann et al. [60] |
Scar formation of laser skin lesions after cold atmospheric pressure plasma (CAP) treatment: a clinical long-term observation | 20 laser lesions in 5 individuals | Plasma treatment seems to support the inflammation needed for tissue regeneration | Acute | Metelmann et al. [58] |
Laser scanning microscopy as a means to assess the augmentation of tissue repair by exposition of wounds to tissue-tolerable plasma | 6 subjects with vacuum-generated wounds | CAP led to a significantly more rapid area decline in comparison to no treatment, treatment with octenidine, and sequential treatment with CAP and octenidine | Acute | Vandersee et al. [57] |
|